Genomic imprinting is an epigenetic phenomenon affecting a small number of genes, which leads to differential expression from the two parental alleles. Imprinted genes are known to regulate fetal growth and a 'kinship' or 'parental conflict' model predicts that paternally and maternally expressed imprinted genes promote and inhibit fetal growth, respectively. In this review we examine the role of imprinted genes in postnatal growth and metabolism, with an emphasis on the GNAS/Gnas locus. GNAS is a complex imprinted locus with multiple oppositely imprinted gene products, including the G-protein a-subunit G s a that is expressed primarily from the maternal allele in some tissues and the G s a isoform XLas that is expressed only from the paternal allele. Maternal, but not paternal, G s a mutations lead to obesity in Albright hereditary osteodystrophy. Mouse studies show that this phenomenon is due to G s a imprinting in the central nervous system leading to a specific defect in the ability of central melanocortins to stimulate sympathetic nervous system activity and energy expenditure. In contrast mutation of paternally expressed XLas leads to opposite metabolic effects in mice. Although these findings conform to the 'kinship' model, the effects of other imprinted genes on body weight regulation do not conform to this model.
Introduction
Genomic imprinting is an epigenetic phenomenon affecting a small number of genes, which results in partial or complete suppression of gene expression from one parental allele. 1 The primary biochemical imprint 'marks' (differences in DNA methylation and/or histone modification) that distinguish the two parental alleles are erased in primordial germ cells, reestablished during oogenesis or spermatogenesis, and maintained in all somatic tissues throughout development. All imprinted genes have one or more regions in which the maternal and paternal alleles are differentially methylated. In many cases DNA methylation is associated with silencing of the affected allele as the methylation occurs within the gene's promoter region. In other cases DNA methylation may be present on the active allele, particularly when the methylation silences a cis-acting negative regulatory element for the gene promoter or when the methylation occurs on a promoter for an interfering RNA.
The most widely accepted hypothesis for why imprinting occurs is the 'kinship' or 'parental conflict' hypothesis, which predicts that the paternally and maternally transmitted alleles promote and inhibit fetal growth, respectively. 2, 3 This model assumes that the father wants to allocate finite resources to his offspring whereas it is in the mother's interest to conserve resources over multiple litters that she will bear throughout life. In addition to their effects on fetal growth, it is clear that imprinted genes also have important roles in postnatal energy metabolism and in many cases obesity is associated with altered function of imprinted genes. Several human genetic disorders affecting imprinted genes lead to obesity and population studies have identified several chromosomal regions associated with parent-of-origin effects on body weight regulation in humans. [4] [5] [6] [7] In this review, we will summarize what is presently known about the role of imprinted genes in the development of obesity and regulation of energy balance, with a particular focus on the GNAS/Gnas locus.
Organization and gene products of GNAS/Gnas
GNAS and the mouse ortholog Gnas are located within syntenic regions at 20q13.2-13.3 and distal chromosome 2, respectively, and have similar overall organization and imprinting patterns. 8 GNAS/Gnas generates multiple gene products through the use of alternative promoters and first exons that splice onto a common exon (exon 2, Figure 1 ). The most downstream alternative promoter generates transcripts encoding the ubiquitously expressed G-protein a-subunit G s a that couples many receptors for hormones, neurotransmitters and other extracellular signals to adenylyl cyclase. 9 G s a is required for receptor-stimulated cAMP production and most of its downstream effects are mediated by cAMP, which in turn activates signaling molecules such as protein kinase A (PKA) and cAMP-regulated guanine nucleotide exchange factors (cAMP-GEFs). PKA is a serine/threonine kinase that acutely activates many metabolic processes such as lipolysis, gluconeogenesis and glycogenolysis through direct phosphorylation of enzymes and other factors involved in intermediary metabolism. In addition, PKA has more chronic effects on gene expression by phosphorylation of transcription factors such as the cAMP response element binding protein. 10 cAMP-GEFs are highly expressed in neuroendocrine cells and may lead to activation of the raslike protein Rap1. There is some evidence that G s a may also stimulate other effectors besides adenylyl cyclase and may also be activated by receptors outside of the seven-transmembrane G-protein-coupled receptor family. 8 The G s a coding region spans 13 exons (12 exons in mice) and generates 2 long and 2 short forms of G s a protein by alternative splicing of exon 3.
9,11 The G s a promoter resides within an unmethylated CpG island (GC-rich region with a high frequency of CpG dinucleotides). 9, [12] [13] [14] Although its promoter is not methylated, G s a is imprinted in a tissuespecific manner, being expressed primarily from the maternal allele in several tissues, including pituitary, thyroid, renal proximal tubules, gonads and the paraventicular nucleus of the hypothalamus, but is biallelically expressed in most tissues. [15] [16] [17] [18] [19] [20] [21] [22] [23] G s a also appears to be imprinted in neonatal brown adipose tissue (BAT), 24 but is not imprinted in adult BAT or white adipose tissue (WAT). [25] [26] [27] Temporal changes in
Gnas regulation appear to occur in adipose tissue in the early postnatal period, as the alternative G s a isoform XLas is expressed in neonatal BAT and WAT but this expression is lost within 1-2 weeks. 28 Splicing to an alternative terminal exon (N1) located between G s a exons 3 and 4 generates a neural-specific truncated splice variant of unknown function (G s aN1).
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The most upstream alternative promoter (referred to as Nesp in the mouse; Figure 1 ) generates transcripts for the neuroendocrine-specific protein of 55 kDa (NESP55). 13, 30, 31 NESP55 is a chromogranin-like protein located within large dense core granules of secretory cells and is presumed to be a cosecretagogue 32 that is totally unrelated to the G-protein a-subunit family. It is primarily expressed in neuroendocrine tissues, including the adrenal medulla, pituitary, hypothalamus and other midbrain and brainstem regions.
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The entire NESP55 coding sequence is within its specific upstream exon and G s a exons 2-13 are within the 3 0 untranslated region of NESP55-specific transcripts. 30, 32 NESP55 is only transcribed from the maternal allele and its promoter region is methylated only on the paternal allele. 13, 30, 36 Imprinting of NESP55 in mice is not established until after implantation, suggesting that this region is not a primary imprinting control region for the GNAS/Gnas locus 14 but rather its imprinting is dependent on the promoter for the antisense transcript Nespas 24 (see Figure 1 and below). Downstream of the Nesp promoter is another alternative promoter (referred to as Gnasxl in the mouse, Figure 1 ) that generates transcripts encoding the G s a isoform XLas. 12, 13, 31, 37, 38 Gnasxl is oppositely imprinted to Nesp, being transcriptionally active only on the paternal allele and methylated on the maternal allele. 12, 13, 36 XLas has a long N-terminal extension encoded by its specific first exon whereas the remainder of the protein encoded by exons 2-13 is identical to G s a. XLas has been shown to be capable of mediating receptor signaling in a similar fashion as G s a in cultured cells. 39 XLas has a more restricted tissue distribution than G s a, being primarily expressed in neuroendocrine tissues including the brain, adrenal medulla, pars intermedia of the pituitary, stomach, heart, kidney and pancreatic islets. 37, [40] [41] [42] Mouse brain regions where XLas is expressed include the hypothalamus, locus coeruleus and the laterodorsal tegmental, hypoglossal, trigeminal, ambiguous, medullary reticular, raphe obscurus and facial nuclei. 42 XLas is expressed in mouse adipose tissue in the early postnatal period but its expression is lost within 2 weeks after birth. 28 High levels of a neural-specific truncated form of XLas (XLN1) are generated by alternative splicing of XLas to alternative terminal exon N1 40 that has been proposed to be potential dominant negative regulator of G s a function. 28, 42 The XLas first exon has been shown to also generate the 44 Just upstream of the XLas promoter and within the same differentially methylated region is the Nespas promoter that generates paternally expressed antisense transcripts that traverse the NESP55 exon. 36, [45] [46] [47] Within the Nespas promoter region is a primary DNA methylation imprint mark in which methylation is established during oogenesis and maintained throughout development. 48 A mouse model in which the Nespas promoter region was deleted confirmed that Nespas is the imprint control center for Nesp and probably is important for normal imprinting throughout the Gnas locus. 24 The exon 1A promoter region (also referred to as exon A/B in humans) located just upstream of G s a exon 1 (Figure 1 ) is within a differentially methylated region that is a primary imprint control region as methylation on the maternal allele is established during oogenesis. 14, 49, 50 Exon 1A generates untranslated transcripts from the paternal allele of unknown function. 14 In pseudohypoparathyroidism type 1B, a form of renal parathyroid hormone resistance, maternal-specific methylation of the exon 1A region is absent due to either a failure to establish or maintain the methylation in this region. [50] [51] [52] [53] On the basis of this observation, it has been suggested that tissue-specific G s a imprinting (suppression of the paternal G s a promoter) is due to the presence of one or more negative regulatory cis-acting elements within the exon 1A differentially methylated region that are both tissue-specific and methylation-sensitive (and therefore does not suppress G s a expression on the methylated maternal allele). Evidence for this model comes from mice in which paternal deletion of the exon 1A region resulted in reversal of G s a imprinting with biallelic expression of G s a in all tissues that were examined.
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Evidence for a role of GNAS in weight regulation in humans
The most direct evidence for an important role of GNAS in the regulation of energy balance comes from patients with Albright hereditary osteodystrophy (AHO), a congenital disorder characterized by the presence of short stature, shortening of various long bones in the hands and feet (brachydactyly), subcutaneous ossifications, rounded face and neurobehavioral abnormalities, which is caused by heterozygous GNAS mutations that disrupt G s a expression or function. 56 Patients in whom the mutation is present on the maternal GNAS allele also develop resistance to various hormones, including parathyroid hormone, thyrotropin, growth hormone-releasing hormone and gonadotropins, a condition known as pseudohypopararthyroidism type 1A (PHP1A) whereas patients with mutations on the paternal allele develop the features of AHO without multihormone resistance, a condition referred to as pseudopseudohypoparathyroidism (PPHP). 15, 56 This is the result of G s a imprinting in specific hormone target tissues: mutation of the active maternal G s a allele leads to severe G s a deficiency and hormone resistance whereas mutation of the inactive paternal allele has little effect on G s a expression or hormone sensitivity. 17, 18, [20] [21] [22] Similar to the parent-of-origin effect on the development of hormone resistance, it has recently been shown that the development of obesity only occurs with maternal, but not paternal, G s a mutations (PHPIA but not PPHP). 57 The obesity generally occurs very early (within the first year) and tends to be severe in early childhood, similar to other monogenic forms of obesity (for example, those secondary to melanocortin 4 receptor (MC4R) mutations). Few studies have been performed in humans examining the underlying mechanism for the obesity in PHPIA. Although one study showed evidence that adipocytes from PHP1A patients have reduced lipolytic responsiveness to epinephrine due to reduced levels of G s a/cAMP signaling, 58 the adipose tissue is unlikely to be involved in this parent-oforigin effect on energy balance as studies have shown no evidence for G s a imprinting in adipose tissue. [25] [26] [27] This same study 58 did show PHP1A patients to have extremely low circulating norepinephrines, even when compared to similarly obese children without PHP1A, suggesting that the defect may lie in central nervous system (CNS) regulation leading to low sympathetic nervous system activity and metabolic rates. Although food intake has not been systematically examined in these patients, one recent case was reported in which severe obesity developed in the first year of life in the absence of hyperphagia, suggesting that low energy expenditure rates may be the major contributor to obesity in this disorder. 59 There is some evidence that growth hormone deficiency due to growth hormone-releasing hormone resistance in the pituitary may contribute to obesity in some cases. 60 Although the incidence of comorbid metabolic abnormalities such as insulin resistance and diabetes in PHP1A has not been systematically examined, recently a case of severe insulin resistance in a young PHP1A patient has been reported. 61 In addition to the monogenic obesity resulting from clear loss-of-function mutations, two single nucleotide polymorphisms have been identified within the GNAS locus that have been associated with altered body weight or response to weight loss regimens. In one study in German women with polycystic ovarian syndrome, the common T393C polymorphism within the GNAS coding region (which does not alter the protein sequence) was associated with increased obesity and insulin resistance, although it should be noted that no such association was noted in their larger control population. 62 A functional polymorphism within the G s a promoter region (G vs A at nucleotide À1211 relative to the G s a translational start site) was shown to be associated with
Imprinted genes and obesity LS Weinstein et al differences in binding of the transcriptional factor upstream stimulatory factor 1, G s a expression levels, lipolytic rates in adipocytes and weight loss on short-term calorie restriction, but was not associated with adiposity at baseline. 63, 64 G s a imprinting underlies the parent-of-origin metabolic effects of GNAS mutations
The initial GNAS knockout line that was developed harbored a large insertion mutation within exon 2 (E2 À ) 17 (the metabolic phenotypes of various Gnas knockout are summarized in Table 1 ). Homozygotes were embryonically lethal. Interestingly, heterozygous E2 À mice showed opposite changes in energy metabolism depending on whether the mutation was present on the maternal (E2 mÀ/ þ ) or paternal
) allele. 65 E2 mÀ/ þ mice developed obesity with increased lipid accumulation in BAT and WAT and proportionally increased serum leptin levels. This obesity was primarily associated with reduced resting and total energy expenditure levels, with no evidence for hyperphagia. These effects seemed to be due to reduced activation of the sympathetic nervous system, as these mice had reduced urine excretion of norepinephrine and its metabolites, normal metabolic and biochemical responsiveness to a b3-adrenergic agonist that only activates adipose tissue, and normal energy expenditure at thermoneutral temperature (30 1C) when sympathetic activity is minimized. 65 Despite the presence of obesity, E2 mÀ had very mild hypolipidemia and slightly improved glucose tolerance and insulin sensitivity with increased insulin-stimulated glucose uptake in isolated skeletal muscles. 65, 66 In contrast, E2 þ /pÀ mice had a severely lean phenotype with markedly increased sympathetic nervous system activity, glucose tolerance and insulin sensitivity that is the result of XLas deficiency (see below). Although NESP55 deficiency could potentially contribute to the E2 mÀ/ þ metabolic phenotype as it is a maternally expressed GNAS gene product that includes exon 2 in its mRNA, this is not likely to be the case, as exon 2 is not within the NESP55 coding region and NESP55 transcripts are still present in E2 mÀ/ þ mice (TX, LSW, unpublished results).
Moreover mice with specific disruption of NESP55 expression do not develop metabolic abnormalities. 67 NESP55 is unlikely to significantly contribute to regulation of energy balance in humans as PHP1B patients with NESP55 deficiency due to imprinting defects involving the NESP55 promoter, leading to promoter methylation on both parental alleles do not appear to be prone to obesity. [70] [71] [72] [73] Recent work shows that G s a imprinting in the CNS underlies the GNAS metabolic phenotype. 23 Mice with
Imprinted genes and obesity LS Weinstein et al Imprinted genes and obesity LS Weinstein et al CNS-specific disruption of maternal G s a allele (mBrGsKO mice), which were generated by mating female G s a E1-floxed mice with male Nestin-cre mice, developed severe obesity starting at age 5-6 weeks, which was at least initially not associated with hyperphagia, but rather with lower sympathetic nervous system activity, energy expenditure rates and activity levels and greater metabolic efficiency (weight gain/ calorie intake). In contrast, mice with CNS-specific disruption of the paternal G s a allele (pBrGsKO mice) maintained a normal phenotype. The effects in mBrGsKO mice were not due to maternal gestational effects as the mothers were Nestin-cre À and therefore had normal G s a expression levels and metabolic phenotype. Thyroid hormone levels were also normal in mBrGsKO mice. In addition to abnormal energy balance, mBrGsKO mice also developed hyperglycemia, glucose intolerance and insulin resistance, whereas glucose metabolism and insulin sensitivity remained normal in pBrGsKO mice. The abnormalities in glucose metabolism and insulin sensitivity in mBrGsKO mice began before the development of obesity and therefore CNS-specific G s a deficiency has a primary effect on peripheral glucose metabolism independent of obesity.
Overall, these findings in BrGsKO mice show that the metabolic phenotype generated by germ-line maternal G s a mutations can be reproduced by loss of maternal G s a expression in the CNS alone and therefore G s a imprinting in the CNS underlies this parent-of-origin effect. Initial studies have shown that G s a undergoes imprinting in the paraventricular nucleus of the hypothalamus, an area known to be important for central regulation of metabolism. 23 In contrast, there was no evidence for G s a imprinting in the nucleus of the solitary tract, another site that is important for metabolic regulation.
G s a mutation leads to loss of stimulation of energy expenditure by central melanocortins
The central melanocortin pathways work downstream of leptin to promote negative energy balance by inhibiting food intake and stimulating sympathetic nervous system activity and energy expenditure. [74] [75] [76] Proopiomelancortin neurons that synthesize and release melanocortins are located in the arcuate nucleus of the hypothalamus where they are stimulated by leptin. These neurons have axonal projections to the paraventricular nucleus and other CNS sites where they synapse with downstream neurons that express the melanocortin receptors MC3R and MC4R. These receptors are classic seven-transmembrane G-proteincoupled receptors that activate G s a/cAMP pathways. MC4R deficiency leads to obesity in both mice and humans, 75, 77, 78 and MC4R receptors mediate the acute effects of melanocortins on food intake and energy expenditure. 79, 80 In addition, MC4R also directly regulates glucose metabolism and peripheral insulin sensitivity. 74, 81, 82 MC3R deficiency leads to only minor changes in adiposity. 75 In many respects mBrGsKO mice have a similar metabolic phenotype to MC4R knockout mice and therefore the primary defect leading to the metabolic consequences of maternal G s a mutation may be resistance to central melanocortin action through loss of MC4R/G s a signaling. In fact the ability of a central melanocortin agonist to acutely stimulate energy expenditure was significantly impaired in mBrGsKO mice. 23 This finding is consistent with the reduction in sympathetic nervous activity and energy expenditure measured at baseline in mBrGsKO, E1 mÀ/ þ , E2 mÀ/ þ and Oed mice, 23, 26, 65, 68, 69 the absence of dietinduced thermogenesis in mBrGsKO mice (which is known to be dependent on MC4R signaling), 23, 83, 84 and the reduction of heart rate and diastolic blood pressure in mBrGsKO mice in the setting of severe obesity. 23 Reduced heart rate and blood pressure was also observed in obese patients and mice with MC4R mutations. 85, 86 Loss of MC4R-mediated stimulation of sympathetic nervous system activity and energy expenditure rates may also underlie the obesity observed in PHP1A patients, as these patients were also shown to have low circulating levels of norepinephrine.
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Although MC4R-mediated effects on sympathetic nervous system activity and energy expenditure were impaired in mBrGsKO mice, the ability of the same melanocortin agonist to acutely inhibit food intake was maintained in these same mice (as well as in E1 mÀ/ þ mice). 23 This finding is consistent with the fact that the onset of obesity in mBrGsKO mice is not associated with hyperphagia and in at least one child Imprinted genes and obesity LS Weinstein et al with PHP1A it was documented that early weight gain occurred in the absence of hyperphagia. 59 Mice with maternal G s a mutation had some of the same features as those of MC4R mutations (obesity, reduced sympathetic nervous system activity and energy expenditure, and impaired glucose metabolism), whereas several features associated with MC4R mutation were absent (hyperphagia, increased linear growth). MC4R signaling stimulates the expression of Sim1, a transcription factor expressed in the paraventricular nucleus that mediates some of the physiological actions of central melanocortins. 87 Sim1 mutations in humans and in mice lead to effects that are reciprocal to those of G s a mutations, namely, obesity primarily due to hyperphagia and increased linear growth, with no effects on energy expenditure or glucose metabolism. [88] [89] [90] [91] [92] Moreover, Sim1 haploinsufficient mice had an impaired anorexic response to administered melanocortins whereas the ability of melanocortins to stimulate energy expenditure in these mice was normal, 88 a pattern opposite to what is observed in mBrGsKO mice. It is therefore possible that melanocortins mediate their physiological effects through multiple pathways downstream of MC4R: a G s adependent pathway that mediates the effects on sympathetic nervous system activity, energy expenditure and glucose metabolism, and a G s a-independent pathway through Sim1 that mediates the effects on food intake and linear growth. Further studies are required to determine whether this model is correct, and if so, what are the signals between MC4R and Sim1 (another G protein such as G q a or a G-proteinindependent signaling mechanism).
XLas has metabolic effects opposite to those of G s a E2 þ /pÀ mice with the E2 À mutation on the paternal allele showed a metabolic phenotype opposite to that of E2 mÀ/ þ mice. 65 Neonatal E2 þ /pÀ mice had poor suckling and most died within hours of birth. Adult E2 þ /pÀ mice were severely lean with markedly reduced lipid accumulation in WAT and BAT. This change in energy balance was primarily due to a marked increase in sympathetic nervous system activity, energy expenditure and activity levels. In addition, E2
þ /pÀ mice had severe hypolipidemia and increased triglyceride clearance with markedly improved glucose tolerance and insulin sensitivity in liver, muscle and adipose tissue. 66, 93 A similar overall phenotype was also observed in mice with the V159E Oed mutation on the paternal allele (referred to as the Sml mutation when on the paternal allele). 68 These mutations disrupt the coding sequences of both G s a and the paternally expressed G s a isoform XLas. In contrast to E2
þ /pÀ and Sml mice, E1 þ /pÀ mice in which only G s a expression from the paternal allele is disrupted developed a marginal increase in adiposity and very mild insulin resistance. 26 It therefore appears likely that the lean, hypermetabolic phenotype observed in E2 þ /pÀ and Sml mice is the direct consequence of XLas deficiency.
An important role for XLas in metabolic regulation in mice was confirmed in mice with specific deficiency of XLas due to a deletion in the upstream XLas first exon (Gnasxl À ). 42 The Gnasxl À deletion had no effect on Gnas imprinting and only produced an abnormal phenotype when it was present on the paternal allele (Gnasxl þ /pÀ ) due to fact that XLas is only expressed from this parental allele. Overall Gnasxl þ /pÀ mice had a phenotype very similar to that of E2 þ /pÀ and Sml mice.
The initial prominent feature was a failure to suckle, which was associated with hypoglycemia and significant neonatal lethality. Reduced suckling in Gnasxl þ /pÀ mice may be a direct effect on orofacial muscle activity as XLas is expressed in CNS nuclei involved in orofacial motor activity, including the facial, hypoglossal and trigeminal nuclei. Rather BAT was overstimulated due to the mice having markedly increased sympathetic nervous system activity as they had increased urinary norepinephrine excretion, 28 similar to E2 þ /pÀ mice.
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On the basis of similar findings in Gnasxl þ /pÀ , E2 þ /pÀ and Sml mice, it is clear that the severe metabolic phenotype found in all of these mice is due to XLas deficiency, which appears to have a dominant effect. It appears that XLas is involved in regulation of sympathetic output from the CNS in a manner opposite to that of G s a. Whether this occurs by acting at CNS sites that are distinct from G s a or whether it directly inhibits G s a signaling remains to be determined. It is unlikely that XLN1 deficiency has a significant role in producing the Gnasxl þ /pÀ phenotype as the Sml exon 6 mutation, which produces a similar phenotype, does not alter the coding sequence of XLN1. 68 Paternal deletion of 20q13 including GNAS has also been associated with feeding difficulties, poor growth and abnormal adipose tissue distribution in humans. 94 However, the significant role that XLas has in metabolic regulation may be species specific, as PPHP patients with paternal GNAS mutations that disrupt XLas expression or function do not produce a similar phenotype.
Tissue-specific G s a knockout models
Important insights into the effects of G s a signaling in specific tissues on metabolic regulation have been derived
Imprinted genes and obesity LS Weinstein et al from various mouse models with tissue-specific G s a deficiency. In these models, both G s a alleles were disrupted and therefore the effects of imprinting are not relevant. Mice with liver-specific G s a deficiency (LGsKO) showed effects consistent with loss of glucagon action in the liver, with reduced gluconeogenesis and increased hepatic glycogen synthesis, along with increased insulin sensitivity in other tissues. 72 LGsKO mice were hypoglycemic and hypoinsulinemic in the fed state but maintained normal glucose and insulin levels after prolonged fasting, probably due to prolonged breakdown of increased hepatic glycogen stores and increased extrahepatic gluconeogenesis.
LGsKO mice also developed pancreatic islet cell hyperplasia with markedly increased circulating glucagon and glucagon-like peptide 1 levels and inappropriately high levels of insulin release in response to administered glucose. In addition,
LGsKO mice had significantly reduced adiposity although the mechanisms underlying this effect on energy balance were not apparent from food intake and energy expenditure studies.
Muscle-specific G s a knockout mice (MGsKO) showed no differences in body weight or composition but did show evidence of glucose intolerance despite the lack of an apparent defect in insulin sensitivity or glucose-stimulated insulin secretion. 73 This may be because these mice had a low muscle mass, confirming an important role for b-adrenergic signaling in maintenance of muscle mass. Interestingly, the skeletal muscle fibers in MGsKO mice appeared to shift toward type 1 slow twitch (aerobic) fibers based upon myosin heavy-chain subtype and kinetic properties but had lower expression of peroxisomal proliferatoractivated receptor g coactivator 1a and lower oxidative metabolic capacity, which is characteristic of type 2 fast twitch (glycolytic) fibers. Therefore, characteristics of muscle fiber type based upon kinetic and other properties can be dissociated from their metabolic characteristics. Finally, mice with loss of G s a expression in pancreatic b cells (bGsKO) developed early postnatal insulin-deficient diabetes with a severe defect in b cell proliferation. 70 Although it has been proposed that G s a signaling promotes b cell growth through activation of the Irs2/Pdx1 pathway, 95 expression of both of these signaling proteins was unaffected in b cells in bGsKO mice. These mice also had a severe defect in linear growth and reduced adiposity.
Prader-Willi and Angelman's syndromes
Prader-Willi syndrome (PWS) is a common congenital disorder that in addition to severe hyperphagia and obesity is also associated with short stature, muscular hypotonia, neurobehavior abnormalities and dysmorphic features. 96 Severe hyperphagia is presumed to be secondary to a primary hypothalamic defect. PWS is also associated with abnormally high levels of the orexigenic peptide ghrelin, although in one study reducing ghrelin levels in PWS patients with somatostatin did not correct the hyperphagia. 97 PWS patients also have increased lipoprotein lipase activity levels, suggesting that in addition to hyperphagia, there may be abnormalities in lipid uptake in adipose tissue. 98 PWS is associated with uniparental disomies, deletions or abnormal imprinting of 15q11-13 leading to loss of expression of a series of contiguous paternally expressed imprinted genes in this region, including NDN, MAGEL2, MKRN3, SNURF-SNRPN and several sno-RNAs. 99 As no specific gene mutation has been found to cause PWS, this disorder is believed to be a contiguous gene syndrome that results from the combined effects of loss of several genes. However, there is some evidence that two of these genes (MAGEL2 and NDN (Necdin)) may be involved in abnormal hypothalamic development underlying the hyperphagia and obesity in PWS. 100 Angelman's syndrome (AS) is characterized by severe mental retardation, ataxia, seizures, a happy disposition and obesity. AS is associated with reciprocal uniparental disomies or deletions of the same 15q11-13 region as that affected in PWS. AS is believed to be primarily due to loss of expression of the ubiquitin protein ligase E3A, the product of the UBE3A gene that is located just telomeric to the PWS region, as mutations affecting this gene have been associated with AS.
101 UBE3A undergoes tissue-specific imprinting in the CNS. However, Ube3a knockout mice did not show clear evidence of obesity. 102, 103 More recent studies have identified another gene ATP10C (encoding an ATPase believed to be phospholipid translocase) located nearby UBE3A that also undergoes brain-specific imprinting and that leads to obesity, glucose intolerance and insulin resistance when mutated in mice.
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Other imprinted genes associated with body weight dysregulation
Initial evidence for an important role for imprinted genes, particularly those that are paternally expressed, in hypothalamic development came from the observation in chimeric mice that androgenetic cells (those disomic for the paternal genome) are prevalent in hypothalamus whereas parthenogenetic cells (those disomic for the maternal genome) are excluded from the hypothalamus. 106 In addition to the potential role of the PWS-associated paternally expressed genes NDN and MAGEL2 in hypothalamic function discussed above, the paternally expressed imprinted gene Peg3 (paternally expressed gene 3) that encodes a zinc-finger protein is expressed in the hypothalamus and Peg3 knockout mice develop obesity in adulthood primarily due to reduced sympathetic nervous system activity and metabolic rate. 107 Although Igf2 (insulin-like growth factor) is a paternally expressed imprinted gene that promotes prenatal growth, one mouse model in which Igf2 expression was reduced in brain developed increased adiposity, suggesting that it may have an opposite effect on postnatal growth. 108 Imprinted genes and obesity LS Weinstein et al Two imprinted genes have been linked to obesity primarily by effects on adipocyte differentiation and function. Pref1/Dlk1 (preadipocyte factor 1/delta, Drosophila homolog-like 1) is a paternally expressed gene that is expressed in preadipocytes and encodes a transmembrane protein that regulates adipocyte differentiation. Pref1/Dlk1 inhibits the differentiation of preadipocytes into mature adipocytes, 109 and Pref1/Dlk1-null mice develop adult-onset obesity 110 whereas mice overexpressing Pref1/Dlk1 in adipose tissue develop a lean phenotype with glucose intolerance. 111 Another imprinted gene that affects adiposity through a primary effect on adipocytes is Peg1/Mest (paternally expressed gene 1/mesoderm-specific transcript) that promotes adipogenesis and obesity when overexpressed and that is induced in WAT in the setting of diet-induced or genetic obesity due to loss of its imprinting.
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Conclusion
The GNAS locus is a unique gene with oppositely imprinted gene products (G s a and XLas) that have opposite effects on energy and glucose metabolism. These reciprocal affects occur primarily through opposite CNS regulation of sympathetic nervous system activity and energy expenditure. The effects of maternal and paternal mutations of the GNAS locus on postnatal growth are consistent with the 'kinship' theory of imprinting, in that paternal Gnas mutation leads to XLas deficiency and a severely lean phenotype in mice whereas maternal GNAS/Gnas mutations in mice and humans lead to G s a deficiency in specific tissues and obesity. However, when one examines the effects of other imprinted genes on adult energy balance, this same pattern does not hold up. For example, obesity is a feature of both PWS and AS even though these two syndromes result from loss of paternally and maternally expressed imprinted genes from the same chromosomal region, respectively. In addition, paternally expressed imprinted genes can have opposite effects on sympathetic nervous system activity and energy expenditure (for example, Gnasxl and Peg3) as well as opposite effects on adipocyte differentiation and function (for example, Peg1/ Mest and Pref1/Dlk1). In addition, both paternally expressed (Peg3) and maternally expressed (Gnas) imprinted genes have similar effects on hypothalamic regulation of sympathetic nervous system activity and energy expenditure.
